(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ... Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...
USA Today: Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL Due to Temperature Excursion During Shipping Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion ...
enoxaparin sodium, Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL Due to Temperature Excursion During Shipping Syringe marking errors, which can lead to incorrect dosing, caused a recall of Enoxaparin Sodium Injection, a generic version of blood clot medication Lovenox. The recall issued Tuesday by Apotex, a ... A steamy shipping glitch has forced Novartis' generics unit to yank a batch of deep vein thrombosis meds from U.S. shelves.
enoxaparin sodium, Sandoz is recalling one lot of enoxaparin sodium injection single-dose ... Techdow USA Inc., a division of the Hepalink Group (Techdow USA), has announced its next finished drug product launch, Enoxaparin Sodium (Enoxaparin). This product is expected to launch in June of ... EurekAlert!: Development of blood clots following long-haul flights prevented with single dose of enoxaparin sodium Development of blood clots following long-haul flights prevented with single dose of enoxaparin sodium Please provide your email address to receive an email when new articles are posted on . Techdow USA announced the FDA approval of its generic enoxaparin sodium for marketing in the U.S. The ...
— The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ... Business Wire: Meitheal Pharmaceuticals Announces Launch of Enoxaparin Sodium Injection, USP in the United States CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated generic injectables company today announced the launch of Enoxaparin Sodium Injection, USP, the generic ... Meitheal Pharmaceuticals Announces Launch of Enoxaparin Sodium Injection, USP in the United States
